Evaluation of Ultrahigh-Field-MRI at 7 Tesla for Imaging of ischemic lesions, carotid plaque morphology and brain perfusion - 7 UP

Organizational Data

DRKS-ID:
DRKS00003193
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2011-08-12
Last update in DRKS:
2012-05-10
Registration type:
Prospective

Acronym/abbreviation of the study

7-UP

URL of the study

No Entry

Brief summary in lay language

The project 7-UP (7 Tesla Ultrahighfield Project) is a pilot study to investigate magnetic resonance imaging (MRI) at 7 Tesla ultrahigh field (UHF) in neurological disease. Compared with the highest available clinical standard with a field strength of 3 Tesla, potential benefits of the higher field strength at 7 Tesla for the diagnosis and therapeutic decision making in disease of the brain and brain supplying blood-vessels will be studied. The potential higher resolution achieved at 7 Tesla may help to depict disturbances of brain blood supply more frequently and in more detail, to assess constricted blood vessels better and to evaluate the blood flow in the brain more accurately. For this purpose, patients after disturbances of brain blood supply (stroke) and with constricted brain supplying blood vessels will be investigated. The study consists of two sessions of magnetic resonance imaging, one at 3 Tesla and another at 7 Tesla.

Brief summary in scientific language

The availability of human ultrahigh-field-magnetic resonance imaging (UHF-MRI) at 7 Tesla opens new possibilities for imaging in neuroscience. It allows for the non-invasive depiction of brain anatomy and pathology with unprecedented resolution: it was shown recently that cavernous hemangiomas could be shown in higher frequency than at 1.5 Tesla; in time-of-flight (TOF)-angiography, more 2nd and 3rd order branches could be seen than at 1.5 or 3 Tesla. Moreover, in patients with multiple sclerosis, 7 Tesla UHF-MRI was not only suited to depict more lesions in contrast to 1.5 Tesla, but cortical lesions were shown for the first time in vivo. Against this background, 7 Tesla UHF-MRI in cerebrovascular disease will be evaluated in this study.

Health condition or problem studied

ICD10:
I63.9 - Cerebral infarction, unspecified
ICD10:
I65.2 - Occlusion and stenosis of carotid artery
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
magnetic resonance maging at 3 Tesla and 7 Tesla

Endpoints

Primary outcome:
part 1: Number of microinfarcts after clinically proven transient ischemic attack, identified by 7 Tesla magnetic resonance imaging (MRI) in comparison to 3 Tesla MRI part 2: Discriminability of core and cap in carotid plaques at 7 Tesla in comparison to 3 Tesla. part 3: Perfusion measurement by ASL at 7 Tesla in comparison to 3 Tesla.
Secondary outcome:
n.a.

Study Design

Purpose:
Basic research/physiological study
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
No Entry

Recruitment period and number of participants

Planned study start date:
2011-08-17
Actual study start date:
2011-08-18
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
100
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
80 Years
Additional Inclusion Criteria:
General inclusion criteria: - Stable patient condition not requiring in-hospital treatment - Age: 18 – 80 years - Preserved ability to give informed consent - Informed consent - Legal competence Specific inclusion criteria - sub-project 1: o TIA o Cortical/sub-cortical infarcts - sub-project 2: o internal or communal carotid artery stenosis (>50%) or as shown by Doppler sonography - sub-project 3: o internal carotid artery stenosis (>70%) or occlusion as shown by Doppler sonography

Exclusion Criteria

Exclusion criteria: - cardiac pacemaker or any other magnetic implant - every kind of metallic or electro-(magnetic) implant - pregnancy and breastfeeding period - claustrophobia - chronic or episodic vertigo - diseases of the retina (e.g. retinal detachment or macula degeneration)

Addresses

Primary Sponsor

Address:
Charité Campus Charité Mitte
Charitéplatz 1
10117 Berlin
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.charite.de
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
CSB-Centrum für Schlaganfallforschung
Univ.-Prof. Dr. Jan Sobesky
Charitéplatz1
11017 Berlin
Germany
Telephone:
030 450 560 010
Fax:
030 450 560 932
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.schlaganfallcentrum.de/

Contact for Public Queries

Address:
CSB-Centrum für Schlaganfallforschung
Univ.-Prof. Dr. Jan Sobesky
Charitéplatz1
11017 Berlin
Germany
Telephone:
030 450 560 010
Fax:
030 450 560 932
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.schlaganfallcentrum.de/

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Bundesministerium für Bildung und Forschung Dienstsitz Berlin
Friedrichstraße 130 B
10117 Berlin
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.bmbf.de

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission des Landes Berlin
Fehrbelliner Platz 1
10707 Berlin
Germany
Telephone:
+49-30-902291220
Fax:
+49-30-90283383
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2010-12-13
Ethics committee number:
10/0563-ZS EK 11
Vote of the Ethics Committee:
Approved
Date of the vote:
2011-03-09

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
Other secondary IDs:
No Entry
Other secondary IDs:
00013854 - DIMDI-Nummer
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry